HIV-1 RT 476-484 (HLA-A*02:01)

HIV-1 RT 476-484 (HLA-A*02:01)
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

5 mg

  • EP07922_1
ILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human... more
Product information "HIV-1 RT 476-484 (HLA-A*02:01)"

ILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*02:01) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*02:01-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell linesILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*02:01) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*02:01-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell linesILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*02:01) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*02:01-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell linesILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*02:01) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*02:01-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell lines

Available downloads:

 
Sequence:ILKEPVHGV
Gene:gag-pol
Delivery: 3 weeks
C-Terminus:NH2
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Gag-Pol polyprotein
Species:HIV-1
Allele:HLA-A*02:01
Application :Flow Cytometry
Indication :AIDS (HIV)
OVA-Q4H7(H-2 Kb) OVA-Q4H7(H-2 Kb)
From €50.00 *
MUC1 (HLA-B*07:02) MUC1 (HLA-B*07:02)
From €50.00 *
MUC1 (HLA-A*02:01) MUC1 (HLA-A*02:01)
From €50.00 *
WT1 (HLA-A*02:01) WT1 (HLA-A*02:01)
From €50.00 *
LLO 91-99 (H-2 Kd) LLO 91-99 (H-2 Kd)
From €50.00 *
3x FLAG Peptide 3x FLAG Peptide
From €170.00 *
MUC1 (HLA-B*07:02) MUC1 (HLA-B*07:02)
From €50.00 *
NEW
Proinsulin 90-104 Proinsulin 90-104
From €100.00 *
Viewed